These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29161076)

  • 1. Obesity and Metabolic Abnormalities in Chronic Obstructive Pulmonary Disease.
    Wouters EFM
    Ann Am Thorac Soc; 2017 Nov; 14(Supplement_5):S389-S394. PubMed ID: 29161076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy.
    Martin M; Almeras N; Després JP; Coxson HO; Washko GR; Vivodtzev I; Wouters EF; Rutten E; Williams MC; Murchison JT; MacNee W; Sin DD; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():451-460. PubMed ID: 28203068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review.
    Cebron Lipovec N; Beijers RJ; van den Borst B; Doehner W; Lainscak M; Schols AM
    COPD; 2016 Jun; 13(3):399-406. PubMed ID: 26914392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic consequences of chronic obstructive pulmonary disease].
    Fekete M; Fazekas-Pongor V; Szőllősi G; Varga JT
    Orv Hetil; 2021 Jan; 162(5):185-191. PubMed ID: 33517332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiles among COPD and controls in the CanCOLD population-based cohort.
    Viglino D; Martin M; Piché ME; Brouillard C; Després JP; Alméras N; Tan WC; Coats V; Bourbeau J; Pépin JL; Maltais F;
    PLoS One; 2020; 15(4):e0231072. PubMed ID: 32275684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
    Stanciu S; Iordache M; Busuioceanu A; Tănăseanu G; Zamfir L; Mureşan M; Bogdan MA
    Rom J Intern Med; 2009; 47(2):123-32. PubMed ID: 20067162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral obesity and different phenotypes of COPD.
    Fimognari FL; Scarlata S; Pastorelli R; Antonelli-Incalzi R
    Am J Respir Crit Care Med; 2009 Jul; 180(2):192-3; author reply 193. PubMed ID: 19578144
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity and chronic obstructive pulmonary disease: recent knowledge and future directions.
    Hanson C; LeVan T
    Curr Opin Pulm Med; 2017 Mar; 23(2):149-153. PubMed ID: 27906857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible link between increased metabolic activity of fat tissue and aortic wall inflammation in subjects with COPD. A retrospective 18F-FDG-PET/CT pilot study.
    Vanfleteren LE; van Meerendonk AM; Franssen FM; Wouters EF; Mottaghy FM; van Kroonenburgh MJ; Bucerius J
    Respir Med; 2014 Jun; 108(6):883-90. PubMed ID: 24785152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic adiposity and cardiometabolic health in COPD.
    Coats V; Després JP; Alméras N; Martin M; Sin DD; Rabasa-Lhoret R; Larose É; Tan WC; Bourbeau J; Maltais F;
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3331-3340. PubMed ID: 30410322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic obstructive pulmonary disease concurrent with metabolic syndrome: Pathophysiological and clinical features].
    Budnevsky AV; Ovsyannikov ES; Labzhania NB
    Ter Arkh; 2017; 89(1):123-127. PubMed ID: 28635909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation and metabolic syndrome in stable COPD patients.
    Akpınar EE; Akpınar S; Ertek S; Sayın E; Gülhan M
    Tuberk Toraks; 2012; 60(3):230-7. PubMed ID: 23030748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D.
    Piazzolla G; Castrovilli A; Liotino V; Vulpi MR; Fanelli M; Mazzocca A; Candigliota M; Berardi E; Resta O; Sabbà C; Tortorella C
    PLoS One; 2017; 12(10):e0186708. PubMed ID: 29065130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism.
    Matsuzawa Y; Funahashi T; Nakamura T
    J Atheroscler Thromb; 2011; 18(8):629-39. PubMed ID: 21737960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Obesity paradox" in chronic obstructive pulmonary disease.
    Blum A; Simsolo C; Sirchan R; Haiek S
    Isr Med Assoc J; 2011 Nov; 13(11):672-5. PubMed ID: 22279700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome in Japan.
    Fujita T
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S15-8. PubMed ID: 18580861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome in COPD patients and its consequences.
    Breyer MK; Spruit MA; Hanson CK; Franssen FM; Vanfleteren LE; Groenen MT; Bruijnzeel PL; Wouters EF; Rutten EP
    PLoS One; 2014; 9(6):e98013. PubMed ID: 24950070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD and the metabolic syndrome: an intriguing association.
    Clini E; Crisafulli E; Radaeli A; Malerba M
    Intern Emerg Med; 2013 Jun; 8(4):283-9. PubMed ID: 21964838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of visceral fat in patients with chronic obstructive pulmonary disease (COPD).
    Lenártová P; Habánová M; Mrázová J; Chlebo P; Wyka J
    Rocz Panstw Zakl Hig; 2016; 67(2):189-96. PubMed ID: 27289515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRISMA-compliant meta-analysis: association of metabolic syndrome and its components with the risk of chronic obstructive pulmonary disease.
    Ye L; Huang X; Wang Q; Yang H; Cai D; Wang Z
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.